China News Service, Beijing, July 13 (Reporter Huang Yuqin) In response to the "Global Immunization Alliance" (GAVI) announced on the 12th that it signed the "New Crown Vaccine Implementation Plan" procurement agreement with Sinopharm Group and Kexing Company, Chinese Foreign Ministry spokesperson Zhao Lijian on the 13th In a regular press conference, it is stated that China will not prioritize its own country, oppose vaccine nationalism, and will continue to make China's contribution to the equitable access to vaccines in developing countries.
Zhao Lijian said that China has been actively supporting and participating in the "New Coronary Vaccine Implementation Plan" and has announced the supply of vaccines to the "Implementation Plan", mainly for the urgent needs of developing countries.
Sinopharm Group and Kexing Company were approved by the WHO for emergency use certification on May 7 and June 1 this year, respectively, to organize and coordinate production guarantees as soon as possible, and actively negotiate with the "Global Immunization Alliance" on the supply of vaccines.
According to the purchase agreement signed by the two parties recently, the two companies will provide 110 million doses of vaccines to the "implementation plan" in the next four months and reach an intention for long-term supply of vaccines.
This is another practical action taken by China to fulfill its promise as a "global public product" for vaccines, promote the fair distribution of vaccines, and help the global fight against the epidemic.
Zhao Lijian pointed out that the world is still in the midst of a pandemic of the new crown pneumonia, and vaccines are the most powerful weapon to defeat the epidemic.
As the largest developing country and a responsible member of the international community, China does not prioritize its own country, opposes vaccine nationalism, always upholds the concept of a human health and health community, and actively promotes vaccine international cooperation with practical actions in order to achieve vaccines in developing countries. The accessibility and affordability of the company have made a tangible contribution.
Up to now, China has provided more than 500 million doses of vaccines and stock solutions to more than 100 countries and international organizations in Asia, Africa, Europe, America and the South Pacific, which is equivalent to one-sixth of the current global vaccine production. The country that provides the largest number of vaccines in China.
Zhao Lijian emphasized that China will continue to make China's contribution to the equitable accessibility of vaccines in developing countries. We also call on capable countries to support and help developing countries obtain vaccines with practical actions as soon as possible, so as to contribute to mankind's early victory over the epidemic.
(Finish)